SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-22-006101
Filing Date
2022-04-25
Accepted
2022-04-25 16:27:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A crsp-defa_14a-2022.htm DEFA14A 37268
2 GRAPHIC img237191599_0.jpg GRAPHIC 667890
3 GRAPHIC img237191599_1.jpg GRAPHIC 833082
  Complete submission text file 0000950170-22-006101.txt   2105452
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37923 | Film No.: 22850014
SIC: 2836 Biological Products, (No Diagnostic Substances)